FGF23 and systemic lupus erythematosus: These results, together with those shown in the present study with respect to FGF23, may indicate that the α-Klotho–FGF23 axis is altered in patients with SLE, with the musculoskeletal manifestations of the disease probably being the most influenced by the dysregulation of this axis.